IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

AstraZeneca Pharma

NSE:ASTRAZEN · ISIN INE203A01020

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
AstraZeneca Pharma

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Action(s) initiated or orders passed - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing
General Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015BSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Communication To The Shareholders W.R.T. TDS On DividendBSE · corporate action · pdf
Source filing
Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
Resignation of Director/KMP/SMP - AstraZeneca Pharma India LimitedNSE · exchange filing · zip
Source filing
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)BSE · exchange filing · pdf
Source filing
General Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
Record Date - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
Shareholders meeting - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Record Date For Payment Of Final DividendBSE · corporate action · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Notice Of The 47Th Annual General MeetingBSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing
AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015BSE · exchange filing · pdf
Source filing
General Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Archived filing
General Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnel (SMP)BSE · exchange filing · pdf
Source filing
General Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management PersonnelBSE · exchange filing · pdf
Source filing
Trading Window - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Resignation of Director/KMP/SMP - AstraZeneca Pharma India LimitedNSE · exchange filing · zip
Source filing
General Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Senior Management PersonnelsBSE · exchange filing · pdf
Source filing
General Updates - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015BSE · exchange filing · pdf
Source filing
Disclosure under SEBI Takeover Regulations - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015BSE · exchange filing · pdf
Source filing
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals - AstraZeneca Pharma India LimitedNSE · exchange filing · pdf
Source filing
AstraZeneca Pharma India Ltd - 506820 - Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Senior Management PersonnelBSE · exchange filing · pdf
Source filing